Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CStone Pharmaceuticals
  6. Societą
    2616   KYG2588M1006

CSTONE PHARMACEUTICALS

(2616)
RiassuntoGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioni 
Attivitą
CStone Pharmaceuticals č una holding di investimento con sede in Cina. Attraverso le sue controllate, la Societą č impegnata principalmente nello sviluppo, nella produzione e nella vendita di prodotti biofarmaceutici. I suoi prodotti principali comprendono farmaci per l'immuno-oncologia e farmaci a bersaglio molecolare. La Societą svolge le sue attivitą principalmente sul mercato nazionale.

Numero di dipendenti : 470 persone.
Vendite per attivitą
20192020Delta
Biopharmaceutical Products--1 167.33100%-
HKD in Milioni
Vendite per regione
2020
United States1 162.0399.5%
China5.300.5%
HKD in Milioni
Dirigenti
Nome Titolo Etą Da
Ning Jun Jiang, Dr. Chairman & Chief Executive Officer 59 2015
Jian Xin Yang, Dr. Chief Medical Officer & Senior Vice President 56 2016
Xin Zhong Wang, Dr. Chief Scientific Officer & Senior Vice President 57 2017
Ting Yuk Wu Independent Non-Executive Director 65 2019
Hong Bin Sun Independent Non-Executive Director 44 2019
Paul Herbert Chew, Dr. Independent Non-Executive Director 68 -
Ning He Board Secretary, Joint Sec & Head-Legal Affairs - 2021
Jeanie Lau Joint Secretary 42 2021
Shirley Zhao General Manager-Greater China & Head-Commercial - 2019
Amministratori
Nome Titolo Etą Da
Ning Jun Jiang, Dr. Chairman & Chief Executive Officer 59 2015
Wei Li, Dr. Non-Executive Director 48 2018
Qun Zhao Non-Executive Director 45 2016
Ting Yuk Wu Independent Non-Executive Director 65 2019
Hong Bin Sun Independent Non-Executive Director 44 2019
Paul Herbert Chew, Dr. Independent Non-Executive Director 68 -
Yan Ling Cao Non-Executive Director 36 2019
Xiang Hong Lin Non-Executive Director 49 2020
Edward Hu Non-Executive Director 57 2021
Azioni
Voto QuantitąFlottanteAutocontrolloFlottante totale
Azione A 1 1 183 845 455 889 300 118 75.1% 0 0.0% 75.1%
Azionisti
NomeAzioni%
6 Dimensions Capital 293 381 444 24,8%
Boyu Capital Advisory Co. Ltd. 146 950 948 12,4%
Pfizer Inc. 115 928 803 9,79%
Suzhou Oriza Holdings Co. Ltd. 98 216 972 8,30%
GIC Special Investments Pte Ltd. 48 392 472 4,09%
Ning Jun Jiang 31 033 617 2,62%
GIC Pte Ltd. (Investment Management) 29 111 000 2,46%
The Vanguard Group, Inc. 12 306 421 1,04%
BlackRock Fund Advisors 9 943 000 0,84%
Templeton Asset Management Ltd. 5 997 000 0,51%
Coordinate societą
CStone Pharmaceuticals Co. Ltd.
1000 Zhangheng Road
Building 25
Pudong New District
Shanghai 201203

Web : http://www.cstonepharma.com
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pił marchi di CStone Pharmaceuticals
Settore Farmaci bioterapeutici